Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business to selling branded GLP-1 weight loss treatments, shifting away ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...

PureHealth Research is proud to introduce its advanced line of Berberine-infused metabolic formulas, developed to work in harmony with the body's own biology. These scientifically formulated products ...

Amazon said customers can access real-time medication availability, transparent pricing, and same-day delivery. ・Citi previously noted that Amazon’s healthcare model still differs from ...

Miami Gardens Clinic Launches Telehealth Access to Tirzepatide and Semaglutide with Same-Day Appointments.

Neuland enters development collaboration with LIR Life Sciences for transdermal GLP-1: Our Bureau, Bengaluru Thursday, May 7, 2026, 13:30 Hrs [IST] Neuland Laboratories, a global ...

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1CDMO to advance biotech’s novel ...

Headquartered in Mississauga, Ontario, Diteba is exceptionally well suited to serve as the anchor laboratory for the program, supported by a robust Quality Management System and a multidisciplinary ...

Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for i nterim analysis first quarter ...

The “magic bullet” model that doctors are most comfortable with is ill-suited to some of the most disabling conditions they ...